Member Info for Brondby

Perhaps they've been overwhelemed by numbers and are focusing on the big spenders only, like lovelyboy 😅

I'm guessing they will filter out the Donald Ducks, Mickey Mouses and Joey Bloggses.

Other possibilities include

- separate webinars for different groups

- admin mess up

Lovelyboy

Where are you seeing 12th August as the new webinar date. I may be missing it, but I can't see anything on the website. And no promotion on their social media, so I'd be surprised if its less than a week away.

I did find Behnke's comment on the Invest page

"We are launching our test in the very near future"

It wouldn't surprise me if launch comes before the webinar. Easier to raise funds for wider marketing if you have the test (or tests) available.

Https://www.openpr.com/news/4131973/cancer-biomarker-testing-market-grows-with-precision-oncology

1. No idea

2. Is a rise of 472% over the last year, and new investment brought on at 20p, not good enough?

You may have a case longer term, of course, but picking the last year is maybe not the best period.

AIM unfortunately.doesn't reflect the true value of companies (as the investment at x6 the then current share price shows) , but is more a reflection of the MM behavour in an AIM market starved of new money, and where existing money flows to the latest "hot share" at the drop of a bitcoin.

Unfortunately, true value on AIM usually only comes through when companies are bought out or are making profits.

Not sure how much of that iis the CEO's fault.

Hopefully we will be in one of the two categories above soon.

Sometimes feel like this share can't do anything without US approval.

You could sell at 2pm each day and buy back after the US opening bell and make a slice every day.

Price brought down to shake some out and attract new buyers awaiting a pullback. Seems to have worked.

Feeling very positive about the future here.

Yes shatter. But it ain't bitcoin treasury so nobody cares 🤣

They will care when the contracts and revenue start to arrive, so I'm looking on it as a buying opp.

To be honest, the chart just looks like a growth trend with pullbacks. In anything that's already done many multiples, there will be profit takers along the way.

Brought it down to close the gap.

Better in the longer term not to leave a gap.

"...that can still being kicked down the road without an end in sight"

Get a grip. In the last 3 years ciz has progressed this test from the lab to the verge of a US launch, solving scalability issues, signing manufacturing agreements, bringing onboard clinical partners like Moffat Cancer

centre, signing a license deal with Ciz Bio.

Bio themselves secured initial funding from HNW individuals and have brought onboard iGenomeDX as its first CLIA lab and signed a contract with Doctors Hospital, which resulted in royalty payments going to ciz. Ciz is now also seeking to progress the test in the UK and Europe (hence the recent Lang funding).

Roll may not be as quick as you would like and have many obstacles along the way, but to claim they are kicking the can down the road is quite simply ludicrous.

And as for the Lang funding, far from being "bizzare", its entirely in line with Ciz strategy to have partners fund the bulk of test rollout, and instead focus on license revenue. But I'm sure Lang will be happy to take advice from our resident cynic and expert in all things - you'll find him on X at GPJersey1

Here's to this potentially life-saving, transformational test hitting the market soon. 👍

"We appear to have invested in bitcoin by mistake" (comic paraphrase)

To be fair, there are likely quite a few in hama in that position!

2p looks like our new support level. Onwards to 3p and beyond.

Not to mention of course, the recent investment at 20p!

Big money coming in at 13p. Yet MMs trying to get retail to sell at 11p 🤦‍♂️

Expect some selling on the news at this level. There will be some people who bought at 6-7p selling or partially selling for a bag.

The news is excellent. And we'll continue the journey upwards in due course. I'm in no hurry for that as I'm still a buyer!

Lol, they've decided the market is asleep and needs a another reminder of the significance of this decision.

Up we go to 20p recent investment level and beyond.

Sorry TT, I said doji and meant hammer! But the result is the same . Friday's increase in volume, hammer candle, coinciding with support suggests to me the bottom is in. Traders may return as you say, but they may also have moved on to bitcoin treasury.

You seem to contradict yourself. One post you're talking of ciz hitting 30m market cap (current mc 6m), the next you're accusing others of being arrogant and lazy thinking this is undervalued! 😆

I think we can agree that the value should be higher than today once a product is actually launched.

But I guess what I'm saying is the current market isn't doing a great job of valuing companies. Maybe it never has, or 50% fluctuations in price with no change in circumstances shouldn't really happen!

Price targets seem rather pointless in the current nano cap market. They are being driven almost entirely by overall sentiment and trader ramping. You need only look at the current bitcoin treasury fad and its rollercoaster impact on share prices.

But underlying value will out in the end. Witness #sym's recent investment at 20p, at a time when its "market value" share price was just over 3p. So much for an efficient market!

#ciz needs to get its product on the market. Until then, its the plaything of traders.

Once that happens, there is little to stop further deals being done across the globe, and takeovers i think come back into play. With a proven product, some larger org may decide they can roll this out quicker with bigger investment.

But until that point, it'll be seen as unproven and risky. Not too long now, IMO.

Friday's doji candle and increased volume may mean the bottom is in again. I'm hoping Bio will have lined up their ducks with some good news in the run up to their investor webinar, or shortly thereafter. Perhaps lab news or some early indications from the Moffat study (Dr. Dalton is on the Bio team). Would make sense to run news like this out at this time.

Its hard to buy any quantity with a live quote.

I had to split my latest 1k buy into two blocks of £500.

And now can't get a live quote for any more than £177.

Feels like this is being held to try to fill an order.

I suspect we may see some delayed buys coming through later. Sell price has been increasing despite some sells.

Either a buy is being being filled or MMs are happy to accumulate shares from silly sells when they know the sp is going to be walked up to 20p.

This is just going to quietly re-rate, no fuss, to around 20p, before next news.

The innefficient AIM market will get there in the end.